# OnCo record sharon-belvin (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/sharon-belvin/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "sharon-belvin" ;
  schema:name "Sharon Belvin"@en ;
  schema:description "Diagnosed with metastatic melanoma at 22, she received the anti-CTLA-4 antibody ipilimumab in an early trial at Memorial Sloan Kettering and has been cancer-free since. Her meeting with James Allison in 2006 is part of immunotherapy's history."@en ;
  schema:url <https://onco.cc/people/sharon-belvin/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://en.wikipedia.org/wiki/James_P._Allison>, <https://www.mskcc.org/> ;
  onco:tag "hero", "patient" ;
  schema:jobTitle "Early complete responder to ipilimumab whose recovery Jim Allison called the moment he knew" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/ctla4/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/aldesleukin/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:people <https://onco.cc/people/james-allison/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-enrolment/>, <https://onco.cc/bottlenecks/b-immunotherapy-response/> .